Turnstone Biologics
Turnstone Biologics Logo
About Turnstone Biologics
Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing next-generation tumor-infiltrating lymphocyte (TIL) therapies and viral immunotherapies for the treatment of solid tumors. Its lead program, TIDAL-01, is in Phase 1 clinical trials for multiple solid tumor types, including breast, colorectal, head and neck cancers, and uveal melanoma. Turnstone is also advancing preclinical programs and combination therapies, leveraging its proprietary approaches to cell therapy and immunotherapy to address unmet needs in cancer treatment. The company is headquartered in the United States and collaborates with leading research institutions to advance its innovative pipeline.
Address
9310 Athena Circle, Suite 300
La Jolla, 92037
United States
Year founded
2018
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
